Beit Jala Pharmaceutical Co (XPAE:BJP) Research & Development: JOD Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Beit Jala Pharmaceutical Co Research & Development?

Beit Jala Pharmaceutical Co XPAE:BJP Research & Development is JOD Mil as of . 20. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Beit Jala Pharmaceutical Co's Research & Development for the six months ended in . 20 was JOD0.00 Mil. Beit Jala Pharmaceutical Co does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Beit Jala Pharmaceutical Co  (XPAE:BJP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Beit Jala Pharmaceutical Co Research & Development Related Terms

Beit Jala Pharmaceutical Co Research & Development Historical Data

* Premium members only.

The historical data trend for Beit Jala Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beit Jala Pharmaceutical Co Research & Development Chart

Beit Jala Pharmaceutical Co Annual Data
Trend
Research & Development

Beit Jala Pharmaceutical Co Semi-Annual Data
Research & Development

Beit Jala Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of JOD Mil mean?
Beit Jala Pharmaceutical Co (XPAE:BJP) has a Research & Development of JOD Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Beit Jala Pharmaceutical Co and its competitors.
Is Beit Jala Pharmaceutical Co's Research & Development too high?
Beit Jala Pharmaceutical Co's current Research & Development is JOD Mil.
How does Beit Jala Pharmaceutical Co's Research & Development compare to ?
Beit Jala Pharmaceutical Co's Research & Development of JOD Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Beit Jala Pharmaceutical Co and its competitors. Beit Jala Pharmaceutical Co's current Research & Development is JOD Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beit Jala Pharmaceutical Co stock overvalued right now?
Beit Jala Pharmaceutical Co (XPAE:BJP) has a current Research & Development of JOD Mil. The current Research & Development is JOD Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Beit Jala Pharmaceutical Co (XPAE:BJP), the current Research & Development is JOD Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beit Jala Pharmaceutical Co Business Description

Comparable Companies
Address 81, Al-Madares Street, Beit Jala, West Bank, Beit Jala, PSE, 97300
Beit Jala Pharmaceutical Co is a manufacturer of pharmaceutical products. The company's products include tablets, capsules, powders, syrups, solutions, oral drops, creams, gels, lotions, medicated shampoo, suppositories and ointments.